OP Asset Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,296
Closed -$117K 809
2026
Q1
$117K Buy
+2,296
New +$107K ﹤0.01% 752
2025
Q2
Sell
-33,622
Closed -$953K 833
2025
Q1
$953K Buy
+33,622
New +$1.19M 0.02% 605

Other funds holding MRNA

OP Asset Management's MRNA Position: Q2 2026 in Review

OP Asset Management sold out of Moderna (MRNA) in Q2 2026, closing a stake of 2,296 shares — an estimated $117K sold.

OP Asset Management first reported a position in MRNA in Q1 2025 and held it in 2 quarters. The position peaked at $953K in Q1 2025. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • OP Asset Management reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • OP Asset Management sold 2,296 Moderna shares in Q2 2026, an estimated $117K.
  • OP Asset Management first reported a position in Moderna in Q1 2025 and held it in 2 quarters.
  • OP Asset Management's Moderna position peaked at $953K in Q1 2025.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.